|
|
|
|
|
Arthritis (AIA) |
|
|
|
| Model: |
Adjuvant induced arthritis in rats (AIA) |
|
| Animal: |
Lewis rat |
|
| Immunogen: |
modified CFA |
|
| Study duration: |
5 weeks (in life) |
|
| Pathological features: |
- |
Marked bone resorption and periosteal bone proliferation |
|
- |
T cell and neutrophil dependent, complement independent |
- |
Cartilage damage to a lesser degree |
- |
B cell invovlvement is minimal |
|
| Suitability: |
- |
COX inhibitor development, general anti-arthritis development |
|
| Parameter measures: |
- |
Body weight |
|
- |
clinical score |
- |
Hind paw swelling |
- |
X-ray examination |
- |
Histo-pathological examination |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
The Latest Generation of Auto Patch Clamp Platform Launched at HDB  |
|
---------------------- |
WuXi Biology/HD Biosciences Presented at Webinar of "New Technologies for Target Discovery and Validation" |
|
---------------------- |
HD Biosciences Merges with WuXi AppTec |
|
|
|
|
|
|
|
|
|
|
沪公网安备 31011502003320号